Jim Simons
CBPO

Jim Simons’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Jim Simons’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-626,789
Closed -$74M – 3917
2020
Q4 		$74M Sell
626,789
-216,238
-26% -$25.1M 0.08% 252
2020
Q3 		$93.7M Buy
843,027
+219,886
+35% +$23.6M 0.09% 227
2020
Q2 		$63.7M Buy
623,141
+371,745
+148% +$39.8M 0.06% 363
2020
Q1 		$27.1M Buy
251,396
+205,696
+450% +$23.6M 0.03% 628
2019
Q4 		$5.32M Buy
45,700
+30,700
+205% +$3.56M ﹤0.01% 1813
2019
Q3 		$1.72M Buy
15,000
+5,900
+65% +$587K ﹤0.01% 2356
2019
Q2 		$867K Sell
9,100
-21,900
-71% -$2.06M ﹤0.01% 2748
2019
Q1 		$2.83M Buy
31,000
+22,900
+283% +$1.87M ﹤0.01% 2134
2018
Q4 		$615K Sell
8,100
-46,700
-85% -$3.44M ﹤0.01% 2787
2018
Q3 		$4.38M Sell
54,800
-68,800
-56% -$6.41M ﹤0.01% 1891
2018
Q2 		$12.3M Buy
123,600
+11,900
+11% +$1.03M 0.01% 1230
2018
Q1 		$9.05M Buy
111,700
+9,400
+9% +$760K 0.01% 1433
2017
Q4 		$8.06M Sell
102,300
-99,800
-49% -$8.3M 0.01% 1510
2017
Q3 		$18.6M Buy
202,100
+120,000
+146% +$11.5M 0.02% 944
2017
Q2 		$9.29M Sell
82,100
-166,900
-67% -$18.7M 0.01% 1320
2017
Q1 		$24.9M Buy
249,000
+102,504
+70% +$11M 0.03% 676
2016
Q4 		$15.8M Sell
146,496
-115,604
-44% -$13.5M 0.02% 935
2016
Q3 		$32.6M Buy
262,100
+33,100
+14% +$3.91M 0.06% 444
2016
Q2 		$24.3M Sell
229,000
-140,700
-38% -$16.3M 0.05% 572
2016
Q1 		$42.3M Sell
369,700
-7,400
-2% -$868K 0.08% 295
2015
Q4 		$53.7M Sell
377,100
-12,000
-3% -$1.39M 0.12% 196
2015
Q3 		$34.9M Buy
389,100
+69,600
+22% +$7.35M 0.08% 290
2015
Q2 		$36.8M Sell
319,500
-29,222
-8% -$3.07M 0.08% 274
2015
Q1 		$33.3M Buy
348,722
+72,622
+26% +$5.43M 0.07% 365
2014
Q4 		$18.6M Buy
276,100
+53,500
+24% +$3.32M 0.04% 549
2014
Q3 		$12M Buy
222,600
+22,500
+11% +$1.11M 0.03% 659
2014
Q2 		$8.9M Buy
200,100
+69,725
+53% +$2.85M 0.02% 909
2014
Q1 		$4.53M Buy
130,375
+11,975
+10% +$381K 0.01% 1316
2013
Q4 		$3.42M Buy
118,400
+23,900
+25% +$693K 0.01% 1430
2013
Q3 		$2.76M Buy
94,500
+9,700
+11% +$242K 0.01% 1507
2013
Q2 		$1.97M Buy
+84,800
New +$2.14M 0.01% 1590

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Jim Simons's CBPO Position: Q1 2021 in Review

Jim Simons sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 626,789 shares — an estimated $74M sold.

Jim Simons first reported a position in CBPO in Q2 2013 and held it in 31 quarters. The position peaked at $93.7M in Q3 2020. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Jim Simons reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Jim Simons sold 626,789 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $74M.
  • Jim Simons first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 31 quarters.
  • Jim Simons's China Biologic Products Holdings, Inc. position peaked at $93.7M in Q3 2020.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.